[Analgesic use in Germany : Survey of the years 2008 to 2019].

IF 1.1 4区医学 Q3 ANESTHESIOLOGY

Schmerz Pub Date : 2023-12-01 Epub Date: 2022-07-21 DOI:10.1007/s00482-022-00661-x

Hans-Christoph Diener, Walter Lehmacher, Elmar Kroth, Anette Lampert, Thomas Weiser

{"title":"[Analgesic use in Germany : Survey of the years 2008 to 2019].","authors":"Hans-Christoph Diener, Walter Lehmacher, Elmar Kroth, Anette Lampert, Thomas Weiser","doi":"10.1007/s00482-022-00661-x","DOIUrl":null,"url":null,"abstract":"Background: There are previously published data on the per capita use of analgesics in Germany, but only to 2005. In the present analysis, data for the years 2008-2019 were evaluated. The use of prescription and nonprescription analgesics was investigated and possible influencing factors were discussed.Materials and methods: The per capita use of prescription and nonprescription analgesics was determined based on data on prescriptions and cash purchases in pharmacies (IMS Pharmascope®, Wiener Neudorf, Austria). Moreover, an evaluation according to active substances was performed for nonprescription drugs. In addition, pharmaceutical manufacturers' advertising expenditures and changes in distribution channels were analyzed as possible influencing factors.Results: During the observation period 2008-2019, the use of prescription analgesics in Germany increased, while the use of nonprescription analgesics decreased. Single-agent drugs constitute the majority of sales of nonprescription analgesics. The share of combination drugs has decreased in recent years.Conclusion: The use of nonprescription analgesics in Germany decreased between 2008 and 2019. The trend as of 1995, which was observed in a previous investigation, is therefore continuing. External factors, such as the increase in advertising expenses or easier access via mail-order pharmacies, do not appear to influence use.","PeriodicalId":21572,"journal":{"name":"Schmerz","volume":" ","pages":"461-466"},"PeriodicalIF":1.1000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663189/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schmerz","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00482-022-00661-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: There are previously published data on the per capita use of analgesics in Germany, but only to 2005. In the present analysis, data for the years 2008-2019 were evaluated. The use of prescription and nonprescription analgesics was investigated and possible influencing factors were discussed.

Materials and methods: The per capita use of prescription and nonprescription analgesics was determined based on data on prescriptions and cash purchases in pharmacies (IMS Pharmascope®, Wiener Neudorf, Austria). Moreover, an evaluation according to active substances was performed for nonprescription drugs. In addition, pharmaceutical manufacturers' advertising expenditures and changes in distribution channels were analyzed as possible influencing factors.

Results: During the observation period 2008-2019, the use of prescription analgesics in Germany increased, while the use of nonprescription analgesics decreased. Single-agent drugs constitute the majority of sales of nonprescription analgesics. The share of combination drugs has decreased in recent years.

Conclusion: The use of nonprescription analgesics in Germany decreased between 2008 and 2019. The trend as of 1995, which was observed in a previous investigation, is therefore continuing. External factors, such as the increase in advertising expenses or easier access via mail-order pharmacies, do not appear to influence use.

查看原文本刊更多论文

[镇痛药在德国的使用:2008 - 2019年的调查]。

背景:以前有关于德国人均镇痛药使用的公布数据，但仅到2005年。在本分析中，对2008-2019年的数据进行了评估。调查了处方和非处方镇痛药的使用情况，并讨论了可能的影响因素。材料和方法:根据药房的处方和现金购买数据(IMS Pharmascope®，Wiener Neudorf，奥地利)确定处方和非处方镇痛药的人均使用量。此外，对非处方药进行了活性物质评价。此外，还分析了制药企业的广告支出和分销渠道的变化作为可能的影响因素。结果:2008-2019年观察期内，德国处方镇痛药的使用增加，非处方镇痛药的使用减少。单药构成非处方镇痛药销售的大部分。近年来，联合用药的比例有所下降。结论:2008年至2019年，德国非处方镇痛药的使用有所下降。因此，在上一次调查中所观察到的1995年的趋势仍在继续。外部因素，如广告费用的增加或通过邮购药店更容易获得，似乎不会影响使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Schmerz 医学-临床神经学

CiteScore

2.00

自引率

20.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Der Schmerz is an internationally recognized journal and addresses all scientists, practitioners and psychologists, dealing with the treatment of pain patients or working in pain research. The aim of the journal is to enhance the treatment of pain patients in the long run. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of pain research, pain management and pain symptom management. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.